Hour24 News
Sophisticated and simple
-
Abcam joins LIGAND-AI to advance AI-driven drug discovery Abcam has joined the Innovative Health Initiative (IHI) LIGAND-AI project, a bold partnership designed to accelerate drug…
-
Introduction: Precigen Demonstrates Set Pace in Commercialization At the 44th Annual J.P. Morgan Healthcare Conference, Precigen highlighted a rapid transition from development to commercial success…
-
Introduction: A growing need in lung cancer therapy Lung cancer remains a leading cause of cancer mortality worldwide, with rising incidence in many regions. Recent…
-
New Partnership to Accelerate Oncolytic Virus Therapy Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and Humane Genomics, a biotechnology company focused…
-
From Lab to Patient: Turning Cell and Gene Therapy into Real Treatments Knut Steffensen is taking on the ambitious task of steering cell- and gene-based…
